- India
- /
- Specialty Stores
- /
- NSEI:PNGJL
N Gadgil Jewellers Full Year 2025 Earnings: EPS: ₹17.10 (vs ₹21.59 in FY 2024)
N Gadgil Jewellers (NSE:PNGJL) Full Year 2025 Results
Key Financial Results
- Revenue: ₹77.3b (up 26% from FY 2024).
- Net income: ₹2.18b (up 41% from FY 2024).
- Profit margin: 2.8% (up from 2.5% in FY 2024). The increase in margin was driven by higher revenue.
- EPS: ₹17.10.
All figures shown in the chart above are for the trailing 12 month (TTM) period
N Gadgil Jewellers Earnings Insights
Looking ahead, revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Specialty Retail industry in India.
Performance of the Indian Specialty Retail industry.
The company's shares are up 4.8% from a week ago.
Risk Analysis
You should learn about the 1 warning sign we've spotted with N Gadgil Jewellers.
Valuation is complex, but we're here to simplify it.
Discover if N Gadgil Jewellers might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:PNGJL
N Gadgil Jewellers
Engages in the retail sale of gems, diamonds, semi-precious stones, and jewellery products in India and the United States.
Solid track record with adequate balance sheet.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Adobe: A Probabilistic Case for Undervaluation

A Capital Allocation Favorite with Structural Importance

Good foundation, but now it's all about the next steps
Recently Updated Narratives

Guanajuanto Silver, Hidden Gem of 1.8M Oz Producer + 75,000m Drilling = Huge Upside

Share gains to fuel earnings momentum
PSP Energy Breaks Key Downtrend, Momentum Building for Further Upside
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

